Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
10 September 2024
| Name: | ANALYTICA LTD (ALT) |
| ISIN: | AU000000ALT0 |
| Date of Listing: | 25 October 2000 |
| Date of Delisting: | 29 August 2023 |
Stock Exchange Status:
This entity was delisted from the Australian Securities Exchange on 29 August 2023.Legal Status:
ACN: 006 464 866ABN: 12 006 464 866
Registration Date: 27 August 1985
Capital Gains Tax (CGT) Status:
This entity is in liquidation, its securities in our opinion, are of little or no value. Previously listed entities that enter external administration, rarely provide a distribution to shareholders unless the winding up is for reasons other than corporate failure. If you are still a holder of securities and seek to realise a capital loss for Capital Gains Tax (CGT) purposes you will need to wait until the liquidator has issued a declaration of loss (a CGT Event) or the entity is deregistered (a CGT Event) or the entity recovers. (Once an entity “progresses” to the liquidation stage, deListed is unable to acquire its securities.).
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
REGISTRY:
Link Market Services Brisbane
Level 21, 10 Eagle Street
Brisbane QLD 4000
Tel : +61 7 3320 2200 or 1300 554 474
Fax : +61 2 9287 0303
RegistryWebsite RegistryEmail
Shareholders in this company should consider crystallising a capital loss in 2024/25 by selling their shares. This process is now much easier and quicker. It can be achieved online by entering transaction details here. While, this usually makes good economic sense we recommend you seek professional advice before buying or selling securities, your accountant is probably the best person. | 10/07/2024 |
liquidator appointed | 25/01/2024 |
delisted for non-payment of annual listing fee under Listing Rule 17.15 | 29/08/2023 |
we understand the entity failed to pay the annual listing fee | 29/08/2023 |
Under Listing Rule 17.6, an entity (if not already suspended) that had not paid its annual listing fees by close of business on Monday, 21 August 2023 would have its securities suspended from Official Quotation before the commencement of trading on Tuesday, 22 August 2023. The following entity has failed to pay to ASX Limited the annual listing fees for the year ending 30 June 2024 and consequently will have its securities suspended from quotation immediately. The company has failed to pay to ASX the annual listing fees for the year ending 30 June 2024, and its securities are already suspended from quotation. | 22/08/2023 |
A second meeting of creditors was held on 20 July 2023 where creditors approved a DOCA proposed by Stratos MedTech and Stratos MedTech Holdings. The DOCA was entered into 24 July 2023. Analytica has entered into and completed the asset sale agreement in accordance with the DOCA under which the Stratos Companies agreed to buy and Analytica agreed to sell its business and assets and shares in Pericoach and Invion. The assets and shares were sold on an 'as is where is' basis with no warranties. The Directors now presently intend to seek shareholders' approval for the delisting and winding up of Analytica by a solvent liquidation following completion of the DOCA, which is expected within approximately 2 months. | 25/07/2023 |
The company releases a notification of cessation of securities. | 21/06/2023 |
The company's voluntary administrators, David Clout and Scott Clout of David Clout & Associates, will seek urgent Expressions of Interest for the sale and/or recapitalisation of the business and/or assets of Analytica. EOIs should be submitted to the Administrators by 5.00pm AEST on 4 July 2023. Further information will be made available to interested parties on request from David Clout & Associates, subject to execution of a suitable confidentiality agreement. The Administrators intend to issue a report to creditors by no later than 10 July 2023 and convene a second meeting of creditors, pursuant to Section 439A of the Corporations Act 2001, to be held on or about 17 July 2023. | 20/06/2023 |
Scott Clout and David Clout have been appointed as Joint and Several Administrators of the Company. | 12/06/2023 |
The final date for exercising the Company's listed options (ASX Code: ALTOB is 5.00pm (AEDT) on 18TH June 2023. The exercise price is A$0.005 cents per Option and for every Option exercised, the Option holder will be issued with one Ordinary Share in Analytica. Options not exercised by 18th June 2023 will automatically lapse and will no longer be available for exercise. Quotation of the options on the ASX will cease on 12 June 2023 (being 5 business days prior to expiry). | 05/05/2023 |
The company lodges its Quarterly Activities/Appendix 4C Cash Flow Report. | 28/04/2023 |
The company issues a response to ASX Query. | 15/03/2023 |
The entity's securities will be suspended from quotation under Listing Rule 17.5 from the commencement of trading today, Wednesday, 1 March 2023, for not lodging the relevant periodic report by the due date. If the report is lodged between the closure of the market announcements office yesterday and the imposition of the suspension, the entity's securities will normally be reinstated to quotation on the next trading day after the suspension is imposed. | 01/03/2023 |
The company lodges its unaudited Appendix 4D and financial report. | 28/02/2023 |
The expiring options of Analytica Limited will be suspended from quotation immediately today, Monday 26 February 2018 pending expiry and removal from official quotation. The Company's fully paid ordinary securities are not affected by this suspension. | 26/02/2018 |
The suspension of trading in the securities of Analytica Limited (the "Company") will be lifted immediately, following the Company's announcement in relation to the proposed capital raising. Security Code: ALT | 03/10/2014 |
Analytica Limited (Company) requests that ASX extends the voluntary suspension of the trading in its securities. | 02/10/2014 |
The securities of Analytica Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement regarding a proposed capital raising. Security Code: ALT | 30/09/2014 |
we understand that on or about this date the company consolidated its shares 1 for 10 | 21/12/2001 |
Shareholders in this company should consider crystallising a capital loss in 2024/25 by selling their shares. This process is now much easier and quicker. It can be achieved online by entering transaction details here. While, this usually makes good economic sense we recommend you seek professional advice before buying or selling securities, your accountant is probably the best person. | 10/07/2024 |
liquidator appointed | 25/01/2024 |
delisted for non-payment of annual listing fee under Listing Rule 17.15 | 29/08/2023 |
we understand the entity failed to pay the annual listing fee | 29/08/2023 |
Under Listing Rule 17.6, an entity (if not already suspended) that had not paid its annual listing fees by close of business on Monday, 21 August 2023 would have its securities suspended from Official Quotation before the commencement of trading on Tuesday, 22 August 2023. The following entity has failed to pay to ASX Limited the annual listing fees for the year ending 30 June 2024 and consequently will have its securities suspended from quotation immediately. The company has failed to pay to ASX the annual listing fees for the year ending 30 June 2024, and its securities are already suspended from quotation. | 22/08/2023 |
A second meeting of creditors was held on 20 July 2023 where creditors approved a DOCA proposed by Stratos MedTech and Stratos MedTech Holdings. The DOCA was entered into 24 July 2023. Analytica has entered into and completed the asset sale agreement in accordance with the DOCA under which the Stratos Companies agreed to buy and Analytica agreed to sell its business and assets and shares in Pericoach and Invion. The assets and shares were sold on an 'as is where is' basis with no warranties. The Directors now presently intend to seek shareholders' approval for the delisting and winding up of Analytica by a solvent liquidation following completion of the DOCA, which is expected within approximately 2 months. | 25/07/2023 |
The company releases a notification of cessation of securities. | 21/06/2023 |
The company's voluntary administrators, David Clout and Scott Clout of David Clout & Associates, will seek urgent Expressions of Interest for the sale and/or recapitalisation of the business and/or assets of Analytica. EOIs should be submitted to the Administrators by 5.00pm AEST on 4 July 2023. Further information will be made available to interested parties on request from David Clout & Associates, subject to execution of a suitable confidentiality agreement. The Administrators intend to issue a report to creditors by no later than 10 July 2023 and convene a second meeting of creditors, pursuant to Section 439A of the Corporations Act 2001, to be held on or about 17 July 2023. | 20/06/2023 |
Scott Clout and David Clout have been appointed as Joint and Several Administrators of the Company. | 12/06/2023 |
The final date for exercising the Company's listed options (ASX Code: ALTOB is 5.00pm (AEDT) on 18TH June 2023. The exercise price is A$0.005 cents per Option and for every Option exercised, the Option holder will be issued with one Ordinary Share in Analytica. Options not exercised by 18th June 2023 will automatically lapse and will no longer be available for exercise. Quotation of the options on the ASX will cease on 12 June 2023 (being 5 business days prior to expiry). | 05/05/2023 |
The company lodges its Quarterly Activities/Appendix 4C Cash Flow Report. | 28/04/2023 |
The company issues a response to ASX Query. | 15/03/2023 |
The entity's securities will be suspended from quotation under Listing Rule 17.5 from the commencement of trading today, Wednesday, 1 March 2023, for not lodging the relevant periodic report by the due date. If the report is lodged between the closure of the market announcements office yesterday and the imposition of the suspension, the entity's securities will normally be reinstated to quotation on the next trading day after the suspension is imposed. | 01/03/2023 |
The company lodges its unaudited Appendix 4D and financial report. | 28/02/2023 |
The expiring options of Analytica Limited will be suspended from quotation immediately today, Monday 26 February 2018 pending expiry and removal from official quotation. The Company's fully paid ordinary securities are not affected by this suspension. | 26/02/2018 |
The suspension of trading in the securities of Analytica Limited (the "Company") will be lifted immediately, following the Company's announcement in relation to the proposed capital raising. Security Code: ALT | 03/10/2014 |
Analytica Limited (Company) requests that ASX extends the voluntary suspension of the trading in its securities. | 02/10/2014 |
The securities of Analytica Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement regarding a proposed capital raising. Security Code: ALT | 30/09/2014 |
we understand that on or about this date the company consolidated its shares 1 for 10 | 21/12/2001 |
Your browser may reflect a date of printing in American format.
Purchases Sales
| DATE | DIRECTOR | NATURE | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|---|
| 18/12/2014 | Michael Monsour | On market | 282,000 | $0.030 | $7,365 |
| 16/12/2014 | Michael Monsour | On market | 65,000 | $0.027 | $1,727 |
| 31/03/2014 | Michael Monsour | On market | 100,000 | $0.027 | $2,700 |
| 11/03/2014 | Michael Monsour | On market | 821,000 | $0.026 | $21,346 |
| 11/03/2014 | Ross Mangelsdorf | On market | 450,000 | $0.026 | $11,700 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Michael Monsour | Executive Chairman | 28/06/2004 |
| Bryan Dulhunty | CFO, Company Secretary | 12/03/2014 |
| Peter Corr | Non Exec Director | 23/05/2017 |
| Ross Mangelsdorf | Executive Director | 07/10/2008 |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Geoff Daly | CEO | 12/02/2014 | 12/05/2023 |
| Thomas Lonngren | Non Exec Director | 10/08/2015 | 18/08/2020 |
| Carl Stubbings | Non Exec Director | 13/01/2014 | 30/11/2017 |
| Warren Brooks | Director | 25/07/2011 | 30/11/2017 |
| David Gooch | Non Exec Director | 30/11/2004 | 25/07/2011 |
| Stephen Jones | Non Exec Chairman | 03/12/2001 | 30/04/2010 |
| Jim Heckathorn | Non Exec Director | 21/07/2009 | |
| Julie Nutting | Non Exec Director | 30/06/2006 | |
| Stephen Goodall | Managing Director | 12/11/2004 | 20/01/2006 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2024 Investogain Pty Limited. All rights reserved.
